Come up with a name for your new list and we'll add to it:
Pulmatrix raised a round of funding on , . Investors include
National Institutes of Health.
Pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. The platform, called iSPERSE (inhaled small particles easily…